Who owns POSEIDA THERAPEUTICS I COM?
- Ticker: PSTX
- CUSIP Number: 73730p108
Tip: Access positions for across all investors
Analyze quarterly positions in Poseida Therapeutics I with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Poseida Therapeutics I stock
Who bought or sold POSEIDA THERAPEUTICS I COM this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
FMR | 15M | $46M | 11% | Mar 2024 |
|
Pentwater Capital Management | 6.0M | $19M | 0% | Mar 2024 |
|
BlackRock | 5.0M | $16M | -2% | Mar 2024 |
|
Boxer Capital | 4.5M | $14M | 100% | Mar 2024 |
|
Vanguard Group | 3.4M | $11M | 16% | Mar 2024 |
|
Geode Capital Management | 1.6M | $5.0M | 10% | Mar 2024 |
|
Aisling Capital Management | 1.0M | $3.5M | 0% | Dec 2023 |
|
William Blair $ Company | 965k | $3.1M | 41% | Mar 2024 |
|
Jacobs Levy Equity Management | 830k | $2.6M | 89% | Mar 2024 |
|
Octagon Capital Advisors | 736k | $2.3M | 100% | Mar 2024 |
|
Millennium Management | 653k | $2.1M | 10% | Mar 2024 |
|
Dimensional Fund Advisors | 590k | $1.9M | 21% | Mar 2024 |
|
Northern Trust | 558k | $1.8M | 3% | Mar 2024 |
|
Charles Schwab Investment Management | 533k | $1.7M | 4% | Mar 2024 |
|
Connor, Clark & Lunn Investment Management | 504k | $1.6M | 35% | Mar 2024 |
|
Morgan Stanley | 469k | $1.5M | 68% | Mar 2024 |
|
Goldman Sachs Group | 451k | $1.4M | -4% | Mar 2024 |
|
Acadian Asset Management | 366k | $1.2M | -57% | Mar 2024 |
|
Jane Street | 330k | $1.1M | 1019% | Mar 2024 |
|
Nuveen Asset Management | 272k | $868k | -25% | Mar 2024 |
|
Susquehanna International | 252k | $805k | 176% | Mar 2024 |
|
MCF Advisors | 247k | $788k | 0% | Mar 2024 |
|
Bank of New York Mellon | 202k | $646k | -12% | Mar 2024 |
|
Bank of America Corporation | 184k | $588k | -22% | Mar 2024 |
|
Citadel Advisors | 163k | $520k | 100% | Mar 2024 |
|
Bridgeway Capital Management | 144k | $458k | -25% | Mar 2024 |
|
Ameriprise Financial | 132k | $420k | 100% | Mar 2024 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 112k | $356k | 455% | Mar 2024 |
|
DekaBank Deutsche Girozentrale | 100k | $302k | 0% | Mar 2024 |
|
Rhumbline Advisers | 93k | $297k | 4% | Mar 2024 |
|
XTX Topco | 91k | $289k | 122% | Mar 2024 |
|
Artia Global Partners | 86k | $274k | 100% | Mar 2024 |
|
American Century Companies | 86k | $273k | 476% | Mar 2024 |
|
Man Group | 80k | $254k | 100% | Mar 2024 |
|
CornerCap Investment Counsel | 80k | $254k | 0% | Mar 2024 |
|
Callan Capital | 79k | $251k | 3% | Mar 2024 |
|
Jpmorgan Chase & Co | 79k | $251k | 70% | Mar 2024 |
|
ExodusPoint Capital Management | 77k | $245k | 100% | Mar 2024 |
|
UBS Group | 75k | $240k | 13% | Mar 2024 |
|
Barclays | 75k | $240k | -38% | Mar 2024 |
|
Cantor Fitzgerald, L. P. | 75k | $240k | 50% | Mar 2024 |
|
Rbf Capital | 70k | $224k | 0% | Mar 2024 |
|
Ohio Pers | 63k | $201k | 177% | Mar 2024 |
|
Balyasny Asset Management | 57k | $181k | 100% | Mar 2024 |
|
Hsbc Holdings | 49k | $161k | 0% | Dec 2023 |
|
Johnson Investment Counsel | 47k | $149k | 0% | Mar 2024 |
|
MetLife Investment Advisors | 36k | $122k | 0% | Dec 2023 |
|
Russell Investments | 35k | $110k | 100% | Mar 2024 |
|
American International | 34k | $114k | 0% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 30k | $95k | 100% | Mar 2024 |
|
SG Americas Securities | 29k | $91k | -23% | Mar 2024 |
|
Forefront Analytics | 27k | $85k | 7% | Mar 2024 |
|
Palumbo Wealth Management | 26k | $83k | 100% | Mar 2024 |
|
Wells Fargo & Company | 24k | $77k | 15% | Mar 2024 |
|
New York State Common Retirement Fund | 23k | $72k | 0% | Mar 2024 |
|
Ing Investment Management | 23k | $72k | -20% | Mar 2024 |
|
Franklin Resources | 22k | $70k | -44% | Mar 2024 |
|
T. Rowe Price Associates | 19k | $61k | 14% | Mar 2024 |
|
Alliancebernstein | 19k | $63k | 0% | Dec 2023 |
|
Keystone Financial Group | 15k | $48k | 0% | Mar 2024 |
|
Creative Planning | 15k | $46k | 7% | Mar 2024 |
|
Citigroup | 13k | $41k | 31% | Mar 2024 |
|
ProShare Advisors | 12k | $39k | -16% | Mar 2024 |
|
AQR Capital Management | 11k | $34k | -54% | Mar 2024 |
|
Bayesian Capital Management | 10k | $33k | 100% | Mar 2024 |
|
Group One Trading | 8.4k | $27k | 100% | Mar 2024 |
|
Marcia E. Wade | 7.6k | $24k | 0% | Mar 2024 |
|
Lazard Asset Management | 7.5k | $0 | -76% | Dec 2023 |
|
California State Teachers Retirement System | 6.8k | $22k | -54% | Mar 2024 |
|
Tower Research Capital | 6.7k | $21k | 32% | Mar 2024 |
|
Legal & General Group | 6.1k | $20k | 0% | Mar 2024 |
|
Summit Investment Advisors | 5.6k | $18k | 0% | Mar 2024 |
|
Us Bancorp | 5.2k | $17k | 100% | Mar 2024 |
|
Metropolitan Life Insurance Company | 3.8k | $13k | 0% | Dec 2023 |
|
Royal Bank of Canada | 2.8k | $0 | -88% | Mar 2024 |
|
Amalgamated Bank | 2.3k | $7.0k | -61% | Mar 2024 |
|
Optimum Investment Advisors | 2.0k | $6.4k | 0% | Mar 2024 |
|
National Bank Of Canada /fi/ | 1.5k | $5.1k | 100% | Dec 2023 |
|
Voisard Asset Management Group | 270.00 | $862.002000 | 0% | Mar 2024 |
|
Farther Finance Advisors | 102.00 | $315.996000 | 0% | Mar 2024 |
|
NISA Investment Advisors | 77.00 | $245.999600 | 88% | Mar 2024 |
|
Nelson, Van Denburg & Campbell Wealth Management | 13.00 | $40.999400 | 100% | Mar 2024 |
|
Who sold out of Poseida Therapeutics I?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Point72 Asset Management | Dec 2023 | 335k | $1.1M |
HighTower Advisors | Dec 2023 | 120k | $402k |
Mirae Asset Global Investments | Dec 2023 | 114k | $383k |
Florida State Board of Administration | Dec 2023 | 18k | $59k |
Cubist Systematic Strategies | Dec 2023 | 17k | $55k |
Mackenzie Financial | Dec 2023 | 14k | $45k |
Dynamic Technology Lab Private | Dec 2023 | 11k | $36k |
FNY Investment Advisers | Dec 2023 | 8.3k | $27k |
Simplex Trading | Dec 2023 | 6.6k | $22k |
Point72 Middle East FZE | Dec 2023 | 5.3k | $18k |
Advisory Services Network | Dec 2023 | 80.00 | $269.000000 |